Miriam Monge to Join Sartorius Stedim Biotech
News Aug 27, 2014
Sartorius Stedim Biotech (SSB) has announced the appointment of Miriam Monge as Director of Marketing for SSB’s Integrated Solutions unit. In this newly created position, Monge will focus on sharpening SSB’s profile as an integrated solution provider for the biopharmaceutical industry.
Miriam Monge brings in more than 20 years of experience in the biopharmaceutical manufacturing sector and served, most recently, as Vice President of Sales & Marketing at the consultancy Biopharm Services.
She is a committee member of the International Society for Pharmaceutical Engineering (ISPE) and one of the founders of the Global Disposable Community of Practice. Miriam Monge regularly authors articles for technical bioprocess journals, analyzing the impact of disposable technologies on biomanufacturing.
“With Miriam Monge, we have gained an internationally recognized expert from the biopharmaceutical industry who will help us further position Sartorius Stedim Biotech as a total solution provider for biopharma companies,” stated Reinhard Vogt, member of the SSB Board of Directors.
Vogt continued, “Whenever our customers start planning a new facility or process, SSB’s Integrated Solutions unit is an ideal partner for designing and implementing entire single-use or hybrid production processes.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.READ MORE